Effects of prior use of non-steroidal anti-inflammatory drugs on renal function and transfusion requirements after upper gastrointestinal haemorrhage D. A. HenryP R. MacGregorC. L. Turner Originals Pages: 341 - 345
Analgesic efficacy of an ibuprofen-codeine combination in patients with pain after removal of lower third molars M. HellmanU. AhlströmS. Strid Originals Pages: 347 - 350
Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue A. J. LawrenceG. P. JoshiD. C. Moriarty Originals Pages: 351 - 355
Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued H. PrzuntekD. WelzelK. Überla Originals Pages: 357 - 363
Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients R. HuupponenA. LehtonenM. Vähätalo Originals Pages: 365 - 368
Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin L. SlungaO. JohnsonG. H. Dahlén Originals Pages: 369 - 373
General well-being during treatment with different ACE-inhibitors: Two double-blind placebo-controlled cross-over studies in healthy volunteers C. DahlöfE. Dimenäs Originals Pages: 375 - 379
The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: Effect of dose, co-medication, and the presence of spina bifida J. G. C. OmtzigtH. NauD. Lindhout Originals Pages: 381 - 388
Phenytoin metabolism during pregnancy M. J. EadieG. E. McKinnonC. M. Lander Originals Pages: 389 - 392
Carbamazepine kinetics and adverse effects during and after ethanol exposure in alcoholics and in healthy volunteers B. SternebringA. LidénA. Melander Originals Pages: 393 - 397
Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers T. GrafF. BrolyH. Howald Originals Pages: 399 - 403
Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism K. Kramer NielsenK. BrøsenDanish University Antidepressant Group Originals Pages: 405 - 411
Drug utilization at primary health care level in southern India J. S. BapnaU. TekurG. Tomson Originals Pages: 413 - 415
Pharmacokinetics of carteolol in patients with impaired renal function M. AmemiyaK. TabeiY. Asano Originals Pages: 417 - 421
Uptake and localisation of O-(β-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy H. A. M. NeumannK. CarlssonG. H. M. Brom Originals Pages: 423 - 426
Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man M. DepréD. J. MargolskeeP. J. De Schepper Originals Pages: 427 - 430
Dose-dependent kinetics of the enantiomers of MK-571, an LTD4-receptor antagonist M. DepréD. J. MargolskeeJ. D. Rogers Short Communications Pages: 431 - 433
Population pharmacokinetic parameters for bayesian monitoring of amikacin therapy in intensive care unit patients J. DebordJ. C. VoultouryR. Gay Short Communications Pages: 435 - 436
Pharmacokinetics of pirmenol in young and elderly subjects D. G. FerryA. J. CampbellI. R. Edwards Short Communications Pages: 437 - 439
The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers A. MunafoT. BuclinJ. Biollaz Short Communications Pages: 441 - 443
Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man C. de MeyD. ElichG. G. Belz Short Communications Pages: 445 - 447
